These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 637492

  • 1. Immune response and non-specific immunotherapy in melanoma.
    El-Domeiri AA.
    Ann R Coll Surg Engl; 1978 Mar; 60(2):117-20. PubMed ID: 637492
    [Abstract] [Full Text] [Related]

  • 2. [Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy].
    Trapeznikov NN, Iavorskiĭ VV, Kadagidze ZG, Malaev SG, Kupin VI.
    Vopr Onkol; 1977 Mar; 23(8):27-33. PubMed ID: 906404
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Possibilities of immunotherapy in malignant melanoma].
    Lewis MG.
    Hautarzt; 1978 Dec; 29(12):619-24. PubMed ID: 363650
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Immunotherapy in malignant melanomaa.
    Homes EC, Morton DL, Eilber FR, Golub SE, Sulit HL.
    Natl Cancer Inst Monogr; 1976 Nov; 44():85-6. PubMed ID: 799763
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary report.
    Nathanson L, Clark DA.
    Natl Cancer Inst Monogr; 1973 Dec; 39():221-4. PubMed ID: 4595321
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Immunotherapy of advanced or metastatic melanoma.
    Cebon J, Gedye C, John T, Davis ID.
    Clin Adv Hematol Oncol; 2007 Dec; 5(12):994-1006. PubMed ID: 18277962
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Results of adjuvant BCG immunotherapy in malignant melanoma.
    Wätzig V, Knopf B.
    Arch Geschwulstforsch; 1981 Dec; 51(6):493-6. PubMed ID: 7332442
    [Abstract] [Full Text] [Related]

  • 17. Adjuvant immunotherapy.
    Goodnight JE, Morton DL.
    Int Adv Surg Oncol; 1978 Dec; 1():53-83. PubMed ID: 399764
    [Abstract] [Full Text] [Related]

  • 18. Immunotherapy of human melanomas and sarcomas.
    Morton DL.
    Natl Cancer Inst Monogr; 1972 Dec; 35():375-8. PubMed ID: 4659050
    [No Abstract] [Full Text] [Related]

  • 19. [Development in the immunotherapy of malignant melanoma].
    Tritsch H.
    Hautarzt; 1976 Jan; 27(1):1-7. PubMed ID: 767300
    [Abstract] [Full Text] [Related]

  • 20. Adjuvant immunostimulation in malignant melanoma with oral Bacille Calmette-Guérin.
    MacGregor AB, Falk RE, Landi S, Ambus U, Samuel ES, Langer B.
    Can J Surg; 1977 Jan; 20(1):25-30. PubMed ID: 832200
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.